therapeuticsmd, inc. is an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their health care issues. we create products to address the unique changes and challenges women experience through every stage of their lives. with momentum fueled by the needs of our customers, we combine entrepreneurial spirit and clinical expertise to develop innovative solutions designed to go beyond what is presently available. this includes a variety of therapies in our pipeline, along with prescription prenatal vitamins under the vitamedmd® and bocagreenmd® brands. see our community guidelines: https://www.therapeuticsmd.com/social-media-community-guidelines
Company profile
Ticker
TXMD
Exchange
Website
CEO
Robert Finizio
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
SEC CIK
Corporate docs
Subsidiaries
VitaMedMD, LLC • BocagreenMD, Inc. ...
IRS number
870233535
TXMD stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
29 Mar 24
8-K
TherapeuticsMD Announces Full Year 2023 Financial Results
29 Mar 24
8-K
TherapeuticsMD Announces Third Quarter 2023 Financial Results
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Entry into a Material Definitive Agreement
18 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
TherapeuticsMD Announces Second Quarter 2023 Financial Results
14 Aug 23
D
Exempt offering of security
10 Jul 23
8-K
Changes in Registrant's Certifying Accountant
10 Jul 23
8-K
Unregistered Sales of Equity Securities
6 Jul 23
Transcripts
TXMD
Earnings call transcript
2022 Q2
15 Aug 22
TXMD
Earnings call transcript
2022 Q1
17 May 22
TXMD
Earnings call transcript
2021 Q4
10 Mar 22
TXMD
Earnings call transcript
2021 Q3
11 Nov 21
TXMD
Earnings call transcript
2021 Q2
4 Aug 21
TXMD
Earnings call transcript
2021 Q1
6 May 21
TXMD
Earnings call transcript
2020 Q4
2 Mar 21
TXMD
Earnings call transcript
2020 Q3
9 Nov 20
TXMD
Earnings call transcript
2020 Q2
7 Aug 20
TXMD
Earnings call transcript
2020 Q1
6 May 20
Latest ownership filings
4
Marlan D Walker
7 Dec 23
144
Notice of proposed sale of securities
6 Dec 23
SC 13D/A
Rubric Capital Management LP
17 Nov 23
4
David Efraim Rosen
17 Nov 23
4
JOSEPH ZIEGLER
21 Aug 23
3
JOSEPH ZIEGLER
21 Aug 23
4
Tommy G Thompson
19 Jul 23
4
Gail K Naughton
19 Jul 23
4
Cooper C. Collins
19 Jul 23
SC 13D/A
Rubric Capital Management LP
30 Jun 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 49.32 mm | 49.32 mm | 49.32 mm | 49.32 mm | 49.32 mm | 49.32 mm |
Cash burn (monthly) | (no burn) | 1.32 mm | 591.00 k | (no burn) | 455.33 k | 1.17 mm |
Cash used (since last report) | n/a | 9.12 mm | 4.09 mm | n/a | 3.15 mm | 8.10 mm |
Cash remaining | n/a | 40.19 mm | 45.22 mm | n/a | 46.16 mm | 41.21 mm |
Runway (months of cash) | n/a | 30.5 | 76.5 | n/a | 101.4 | 35.2 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 39 |
Opened positions | 3 |
Closed positions | 9 |
Increased positions | 7 |
Reduced positions | 6 |
13F shares | Current |
---|---|
Total value | 9.34 bn |
Total shares | 35.00 mm |
Total puts | 13.40 k |
Total calls | 37.00 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Flynn James E | 20.66 mm | $23.14 mm |
Smith Robert J | 11.35 mm | $0.00 |
Rubric Capital Management | 1.19 mm | $3.60 bn |
Clearline Capital | 455.39 k | $1.38 bn |
Vanguard | 385.25 k | $1.16 bn |
Tejara Capital | 369.59 k | $1.12 bn |
BLK Blackrock | 136.51 k | $412.25 mm |
MS Morgan Stanley | 133.14 k | $402.10 mm |
Geode Capital Management | 84.79 k | $256.13 mm |
Bridgeway Capital Management | 42.00 k | $126.84 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Dec 23 | Marlan D Walker | Common Stock | Sell | Dispose S | No | No | 2.239 | 4,550 | 10.19 k | 62,565 |
6 Dec 23 | Marlan D Walker | Common Stock | Sell | Dispose S | No | No | 2.3101 | 14,500 | 33.50 k | 67,115 |
5 Dec 23 | Marlan D Walker | Common Stock | Option exercise | Acquire M | No | No | 0 | 70,000 | 0.00 | 81,615 |
5 Dec 23 | Marlan D Walker | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 70,000 | 0.00 | 0 |
15 Nov 23 | Rubric Capital Management | Common Stock, par value $0.001 per share ("Common Stock") | Grant | Acquire A | Yes | No | 2.28 | 877,192 | 2.00 mm | 2,946,908 |
17 Aug 23 | Joseph Ziegler | Common Stock | Grant | Acquire A | No | No | 0 | 7,500 | 0.00 | 7,500 |
17 Jul 23 | Collins Cooper C. | RSU Common Stock | Grant | Acquire A | No | No | 0 | 8,500 | 0.00 | 8,500 |